Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,367

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors

Open access
Danaei, Goodarz, Vander Hoorn, Stephen, Lopez, Alan D, Murray, Christopher JL, Ezzati, Majid·2005·The Lancet
DOI 10.1016/s0140-6736(05)67725-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(05)67725-2

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. Hunink, 1997, The recent decline in mortality from coronary heart disease, 1980–1990: the effect of secular trends in risk factors and treatment, JAMA, 277, 535, 10.1001/jama.1997.03540310033031 · DOI
  2. Jemal, 2003, Cancer statistics, 2003, C A Cancer J Clin, 53, 5, 10.3322/canjclin.53.1.5 · DOI · Paper page
  3. Chu, 2003, Trends in prostate cancer mortality among black men and white men in the United States, Cancer, 97, 1507, 10.1002/cncr.11212 · DOI
  4. Weir, 2003, Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control, J Natl Cancer Inst, 95, 1276, 10.1093/jnci/djg040 · DOI · Paper page
  5. Shapiro, 1997, Periodic screening for breast cancer: the HIP randomized controlled trial, J Natl Cancer Inst Monogr, 22, 27, 10.1093/jncimono/1997.22.27 · DOI · Paper page
  6. 2001, Tamoxifen for early breast cancer, Cochrane Database Syst Rev, 1
  7. Doll, 1990, Are we winning the fight against cancer? An epidemiological assessment, Eur J Cancer, 26, 500, 10.1016/0277-5379(90)90025-O · DOI
  8. Dikshit, 2000, Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India, Int J Epidemiol, 29, 609, 10.1093/ije/29.4.609 · DOI
  9. Liu, 1998, Emerging tobacco hazards in China: 1, retrospective proportional mortality study of one million deaths, BMJ, 317, 1411, 10.1136/bmj.317.7170.1411 · DOI · Paper page
  10. Madigan, 1995, Proportion of breast cancer cases in the United States explained by well-established risk factors, J Natl Cancer Inst, 87, 1681, 10.1093/jnci/87.22.1681 · DOI · Paper page
  11. Mezzetti, 1998, Population attributable risk for breast cancer: diet, nutrition, and physical exercise, J Natl Cancer Inst, 90, 389, 10.1093/jnci/90.5.389 · DOI
  12. Engel, 2003, Population attributable risks of esophageal and gastric cancers, J Natl Cancer Inst, 95, 1404, 10.1093/jnci/djg047 · DOI
  13. Pisani, 1997, Cancer and infection: estimates of the attributable fraction in 1990, Cancer Epidemiol Biomarkers Prev, 6, 387
  14. Parkin, 2001, Cancer burden in the year 2000: the global picture, Eur J Cancer, 37, S4, 10.1016/S0959-8049(01)00267-2 · DOI · Paper page
  15. Ezzati, 2002, Selected major risk factors and global and regional burden of disease, Lancet, 360, 1347, 10.1016/S0140-6736(02)11403-6 · DOI · Paper page
  16. Mathers, 2002, Global and regional estimates of cancer mortality and incidence by site: I, application of regional cancer survival model to estimate cancer mortality distribution by site, BMC Cancer, 2, 36, 10.1186/1471-2407-2-36 · DOI
  17. Shibuya, 2002, Global and regional estimates of cancer mortality and incidence by site: II, results for the global burden of disease 2000, BMC Cancer, 2, 37, 10.1186/1471-2407-2-37 · DOI
  18. Ezzati, 2003, Estimates of global and regional potential health gains from reducing multiple major risk factors, Lancet, 362, 271, 10.1016/S0140-6736(03)13968-2 · DOI · Paper page
  19. Laara, 1987, Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes, Lancet, 1, 1247, 10.1016/S0140-6736(87)92695-X · DOI · Paper page
  20. Gustafsson, 1997, International incidence rates of invasive cervical cancer after introduction of cytological screening, Cancer Causes Control, 8, 755
  21. Mandel, 1993, Reducing mortality from colorectal cancer by screening for fecal occult blood, N Engl J Med, 328, 1365, 10.1056/NEJM199305133281901 · DOI · Paper page
  22. Hardcastle, 1996, Randomised controlled trial of faecal-occult-blood screening for colorectal cancer, Lancet, 348, 1472, 10.1016/S0140-6736(96)03386-7 · DOI
  23. Kronborg, 1996, Randomised study of screening for colorectal cancer with faecal-occult-blood test, Lancet, 348, 1467, 10.1016/S0140-6736(96)03430-7 · DOI
  24. Hackshaw, 2003, EUSOMA review of mammography screening, Ann Oncol, 14, 1193, 10.1093/annonc/mdg321 · DOI
  25. Freedman, 2004, On the efficacy of screening for breast cancer, Int J Epidemiol, 33, 43, 10.1093/ije/dyg275 · DOI
  26. Annie Yu, 2003, Hereditary nonpolyposis colorectal cancer: preventive management, Cancer Treat Rev, 29, 461, 10.1016/S0305-7372(03)00084-7 · DOI
  27. Manser, 2004, Screening for lung cancer, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD001991.pub2 · DOI
  28. Harper, 2004, Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial, Lancet, 364, 1757, 10.1016/S0140-6736(04)17398-4 · DOI · Paper page
  29. Villa, 2005, Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial, Lancet Oncol, 6, 271, 10.1016/S1470-2045(05)70101-7 · DOI · Paper page
  30. Sporn, 1996, The war on cancer, Lancet, 347, 1377, 10.1016/S0140-6736(96)91015-6 · DOI · Paper page

Cited by

See all 1,367

Metadata

Authors
Danaei, G., Vander Hoorn, S., Lopez, A. D., Murray, C. J., & Ezzati, M.
Venue
The Lancet
Publisher
Elsevier BV
Published
2005-11
Volume
366
Issue
9499
Pages
1784-1793
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(05)67725-2
OpenAlex
W2152576550
Cited by
1,367
References
1
FWCI
15.69
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.